6.
Zhang P, Lai Z, Chen H, Zhang M, Wang A, Jia T
. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice. J Exp Clin Cancer Res. 2017; 36(1):190.
PMC: 5741949.
DOI: 10.1186/s13046-017-0661-7.
View
7.
Sasaki K, Tsuno N, Sunami E, Tsurita G, Kawai K, Okaji Y
. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer. 2010; 10:370.
PMC: 2914703.
DOI: 10.1186/1471-2407-10-370.
View
8.
Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N
. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci. 2020; 111(9):3142-3154.
PMC: 7469786.
DOI: 10.1111/cas.14532.
View
9.
Hu F, Li G, Huang C, Hou Z, Yang X, Luo X
. The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation. Cell Death Dis. 2020; 11(5):304.
PMC: 7195408.
DOI: 10.1038/s41419-020-2467-3.
View
10.
Ghafouri-Fard S, Abak A, Tondro Anamag F, Shoorei H, Fattahi F, Javadinia S
. 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent. Front Oncol. 2021; 11:658636.
PMC: 8092118.
DOI: 10.3389/fonc.2021.658636.
View
11.
Sethy C, Kundu C
. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021; 137:111285.
DOI: 10.1016/j.biopha.2021.111285.
View
12.
Meschini S, Pellegrini E, Condello M, Occhionero G, Delfine S, Condello G
. Cytotoxic and Apoptotic Activities of Prunus spinosa Trigno Ecotype Extract on Human Cancer Cells. Molecules. 2017; 22(9).
PMC: 6151690.
DOI: 10.3390/molecules22091578.
View
13.
Uray I, Uray K
. Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface. Int J Mol Sci. 2021; 22(21).
PMC: 8584042.
DOI: 10.3390/ijms222111566.
View
14.
Vasan N, Baselga J, Hyman D
. A view on drug resistance in cancer. Nature. 2019; 575(7782):299-309.
PMC: 8008476.
DOI: 10.1038/s41586-019-1730-1.
View
15.
Karakas N, Okur M, Ozturk I, Ayla S, Karadag A, Cicek Polat D
. Antioxidant Activity of Blackthorn (Prunus spinosa L.) Fruit Extract and Cytotoxic Effects on Various Cancer Cell Lines. Medeni Med J. 2020; 34(3):297-304.
PMC: 7433737.
DOI: 10.5222/MMJ.2019.87864.
View
16.
Guo G, Wang Y, Zhang Y, Chen X, Lu J, Wang H
. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World J Gastroenterol. 2019; 25(15):1840-1853.
PMC: 6478617.
DOI: 10.3748/wjg.v25.i15.1840.
View
17.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A
. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249.
DOI: 10.3322/caac.21660.
View
18.
Wang C, Li F, Zhang T, Yu M, Sun Y
. Recent advances in anti-multidrug resistance for nano-drug delivery system. Drug Deliv. 2022; 29(1):1684-1697.
PMC: 9154776.
DOI: 10.1080/10717544.2022.2079771.
View
19.
Moutabian H, Majdaeen M, Ghahramani-Asl R, Yadollahi M, Gharepapagh E, Ataei G
. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities. Cancer Cell Int. 2022; 22(1):142.
PMC: 8976963.
DOI: 10.1186/s12935-022-02561-7.
View
20.
Sasaki K, Tsuno N, Sunami E, Kawai K, Hongo K, Hiyoshi M
. Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anticancer Drugs. 2012; 23(7):675-82.
DOI: 10.1097/CAD.0b013e328353f8c7.
View